Proactive Investors - Finance
16 Oct 2025, 15:21 UTC · 51w ago
Impact · against what's priced in
HeLIX Exploration and Medicus Pharma both hit material positive milestones. HeLIX provides technical evidence for high-value mantle helium and natural hydrogen potential, while Medicus Pharma advances its regulatory timeline via an FDA protocol submission.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish
HeLIX Exploration announced breakthrough results confirming both mantle helium and geological hydrogen potential at its Rudyard Project in Montana.
So whatPositive exploration results for high-value commodities like helium and hydrogen typically drive significant valuation increases for small-cap explorers.
More positive than 94% of claims this week
Medicus Pharma has submitted Protocol SKNJCT-005 for its SkinJect program to the U.S. FDA.
Continue reading
5 related stories
The discovery of serpentine, olivine, and magnetite minerals suggests natural hydrogen generation, while ³He/⁴He ratios 3,600% above continental levels confirm a mantle helium component.
Read from the article alone
No priced-in read yet
The company has moved the SkinJect program closer to potential commercialization by submitting Protocol SKNJCT-005 to the FDA.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 80% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company announced breakthrough results confirming significant potential for geological hydrogen and mantle helium at its flagship project.
More positive than 90% of ticker scores this week
The company reached a significant regulatory milestone by submitting its SkinJect program protocol to the FDA.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
3h ago
—
No price for HEX right now — the quote feed didn't answer.
HEX chart →−89.9%
Price is moving against the score
$2.93 vs $29.04 close before publication (Oct 15) · not market-adjusted
MEDS chart →
